Eligi
Med
Base de datos
Seguridad
Sobre EligiMed
Contáctenos
Ensayos Clínicos de Enfermedades Infecciosas | EligiMed
Ensayos clínicos
887 ensayos encontrados
Completado
ClinicalTrials.gov
Effectiveness and Safety Study of Specific Hyperimmune Equine Serum for the Treatment of Severe Hospitalized SARS-CoV-2 in Adults: Retrospective Cohort Study
Observacional
Inicio: 22 de may de 2021
ID: NCT04954235
Completado
Fase 4
ClinicalTrials.gov
EPICOS: Evaluación de la Influencia de la Nutrición Parenteral RTU en los Resultados Clínicos de los Pacientes
Intervencional
Inicio: 1 de jul de 2008
ID: NCT00798681
Por invitación
ClinicalTrials.gov
Tamizaje masivo de enfermedad de Chagas entre ingresantes universitarios como estrategia para mejorar el acceso al diagnóstico y tratamiento en la provincia de Salta, Argentina
Observacional
Inicio: 11 de sept de 2024
ID: NCT07033325
Completado
Fase 2
ClinicalTrials.gov
A Phase II/III 48-Week, Randomized, Double-Blind, Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Lamivudine 300mg Once Daily Vs. Lamivudine 150mg BID in Combination With Zidovudine 300mg BID and Efavirenz 600mg Once Daily in Antiretroviral-Naive Adults With HIV-1 Infection
Intervencional
Inicio: 1 de sept de 1999
ID: NCT00004852
Completado
Fase 2
ClinicalTrials.gov
Estudio de fase II, aleatorizado, para evaluar la inmunogenicidad y seguridad de esquemas heterólogos de vacunación contra SARS-CoV-2 (rAd26-rAd5, ChAdOx1 nCoV-19 y BBIBP-CorV).
Intervencional
Inicio: 5 de jul de 2021
ID: NCT04962906
Completado
ClinicalTrials.gov
Biomarker Study to Identify Subjects With Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations
Observacional
Inicio: 1 de ago de 2019
ID: NCT03955913
Terminado
Fase 3
ClinicalTrials.gov
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Intervencional
Inicio: 1 de dic de 2010
ID: NCT01110408
Completado
Fase 3
ClinicalTrials.gov
A PHASE 1/2/3, PLACEBO-CONTROLLED, RANDOMIZED, OBSERVER-BLIND, DOSE-FINDING STUDY TO EVALUATE THE SAFETY, TOLERABILITY, IMMUNOGENICITY, AND EFFICACY OF SARS-COV-2 RNA VACCINE CANDIDATES AGAINST COVID-19 IN HEALTHY INDIVIDUALS
Intervencional
Inicio: 29 de abr de 2020
ID: NCT04368728
Completado
Fase 4
ClinicalTrials.gov
Treatment With Inhaled Corticosteroids in Patients Hospitalized Because of COVID19 Pneumonia
Intervencional
Inicio: 21 de abr de 2020
ID: NCT04355637
Completado
Fase 3
ClinicalTrials.gov
A Phase 3 Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate the Antiretroviral Activity, Safety, and Tolerability of Doravirine/Islatravir Once-Daily in HIV-1 Infected Treatment-Naïve Participants
Intervencional
Inicio: 28 de feb de 2020
ID: NCT04233879
Desconocido
Fase 3
ClinicalTrials.gov
NOVATION-1: A Randomized, Double-Blind, Placebo-Controlled, Phase III Study to Evaluate the Safety and Efficacy of Aerosolized Novaferon + SOC vs. Placebo + SOC in Hospitalized Adult Patients With Moderate to Severe COVID-19
Intervencional
Inicio: 10 de jun de 2021
ID: NCT04669015
Completado
ClinicalTrials.gov
Randomized, Double-blind, Placebo-controlled Clinical Trial of Convalescent Plasma for the Treatment of COVID-19 Pneumonia With Severity Criteria
Intervencional
Inicio: 15 de may de 2020
ID: NCT04383535
Terminado
Fase 3
ClinicalTrials.gov
Reparixin 1200 mg TID as add-on to SoC to Limit Disease Progression in Hospitalised Patients With COVID-19 and Other Community-Acquired Pneumonia. A Multicentre, Randomized, Double-blinded, Placebo-controlled, Phase III Trial (REPAVID-22)
Intervencional
Inicio: 27 de abr de 2022
ID: NCT05254990
Completado
ClinicalTrials.gov
Lesión pulmonar (edema pulmonar) en COVID-19: tratamiento con furosemida y balance hídrico negativo (NEGBAL): un estudio de casos y controles
Observacional
Inicio: 28 de nov de 2021
ID: NCT05304702
Completado
Fase 3
ClinicalTrials.gov
A Phase IIIB, Randomized, Controlled, Observer-blind Study to Evaluate Safety and Immunogenicity of GSK's Meningococcal ABCWY Vaccine When Administered in Healthy Adolescents and Adults, Previously Primed With Meningococcal ACWY Vaccine
Intervencional
Inicio: 25 de ene de 2021
ID: NCT04707391
Completado
Fase 3
ClinicalTrials.gov
Estudio de fase 3 con asunaprevir y daclatasvir (DUAL) para respondedores nulos o parciales a interferón pegilado alfa y ribavirina (P/R), sujetos intolerantes o no elegibles a P/R y sujetos sin tratamiento previo con infección crónica por hepatitis C genotipo 1b
Intervencional
Inicio: 1 de may de 2012
ID: NCT01581203
Desconocido
Fase 4
ClinicalTrials.gov
Efficacy of a Nasal Spray Containing Iota-Carrageenan in the Prophylaxis of COVID-19 Disease in Health Personnel Dedicated to Patients Care With COVID-19. Multicenter, Randomized, Double-blind, Placebo-controlled Trial (CARR-COV-02)
Intervencional
Inicio: 24 de jul de 2020
ID: NCT04521322
Completado
Fase 3
ClinicalTrials.gov
An Open Label, Phase II Study of Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Subjects Following Failure With Kaletra (Lopinavir/Ritonavir) as Their Second Protease Inhibitor.
Intervencional
Inicio: 1 de abr de 2001
ID: NCT00038519
Completado
ClinicalTrials.gov
A Randomized Double-Blind Study Comparing Oseltamivir Versus Placebo for the Treatment of Influenza in Low Risk Adults
Intervencional
Inicio: 1 de abr de 2011
ID: NCT01314911
Completado
Fase 3
ClinicalTrials.gov
Atazanavir (BMS-232632) for HIV Infected Individuals Completing Atazanavir Clinical Trials: An Extended Access Study
Intervencional
Inicio: 1 de oct de 2002
ID: NCT01003990
Anterior
1
...
38
39
40
...
45
Siguiente
Filtros
1